Cargando…

The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study

AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) Wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lenian, Lin, Shanyi, Zhu, Hongyi, Dong, Yang, Yang, Qingcheng, Yuan, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892695/
https://www.ncbi.nlm.nih.gov/pubmed/35241034
http://dx.doi.org/10.1186/s12891-022-05157-4
_version_ 1784662232457543680
author Zhou, Lenian
Lin, Shanyi
Zhu, Hongyi
Dong, Yang
Yang, Qingcheng
Yuan, Ting
author_facet Zhou, Lenian
Lin, Shanyi
Zhu, Hongyi
Dong, Yang
Yang, Qingcheng
Yuan, Ting
author_sort Zhou, Lenian
collection PubMed
description AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) What’s the impact of tourniquet usage on the risk of recurrence from high blood pressure? METHODS: This retrospective study evaluated patients receiving intralesional curettage for primary bone tumors from January 2011 to January 2015. A total of 411 patients with a minimum five-year follow-up were included for analysis. Demographic and disease-related variables were first assessed in univariable analyses for local recurrence risk. When a yielded p-value was < 0.2, variables were included in multivariable analyses to identify independent risk factors for local recurrence. Patients were then stratified by tourniquet usage (use/non-use), and risk from high blood pressure was evaluated in both subgroups. RESULTS: At an average follow-up of 6.8 ± 1.0 years, 63 of 411 patients (15.3%) experienced local recurrence. In multivariable analyses, local recurrence was associated with age (OR, 0.96; 95% CI, 0.94–0.99; p = 0.005); tumor type; lesion size (> 5 cm: OR, 3.58; 95% CI, 1.38–9.33; p = 0.009); anatomical site (proximal femur: OR, 2.49; 95% CI, 1.21–5.15; p = 0.014; proximal humerus: OR, 3.34; 95% CI, 1.61–6.92; p = 0.001); and preoperative mean arterial pressure (> 110 mmHg: OR, 2.61; 95% CI, 1.20–5.67; P = 0.015). In subgroup analyses, after adjusting for age, tumor type, lesion size, and anatomical site, tourniquet use modified the preoperative mean arterial pressure - recurrence relationship: when tourniquet was not used, preoperative mean arterial pressure predicted local recurrence (95–110 mmHg, 4.13, 1.42–12.03, p = 0.009; > 110 mmHg, 28.06, 5.27–149.30, p < 0.001); when tourniquet was used, preoperative mean arterial pressure was not related to local recurrence (all p values > 0.05). CONCLUSIONS: A high preoperative blood pressure was related to local recurrence after intralesional curettage for primary bone tumors in our study. Tourniquet usage and controlling blood pressure might be beneficial for reducing local recurrence in patients scheduled to receive intralesional curettage for primary bone tumor treatment. LEVEL OF EVIDENCE: Level IV, hypothesis-generating study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05157-4.
format Online
Article
Text
id pubmed-8892695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88926952022-03-10 The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study Zhou, Lenian Lin, Shanyi Zhu, Hongyi Dong, Yang Yang, Qingcheng Yuan, Ting BMC Musculoskelet Disord Research AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) What’s the impact of tourniquet usage on the risk of recurrence from high blood pressure? METHODS: This retrospective study evaluated patients receiving intralesional curettage for primary bone tumors from January 2011 to January 2015. A total of 411 patients with a minimum five-year follow-up were included for analysis. Demographic and disease-related variables were first assessed in univariable analyses for local recurrence risk. When a yielded p-value was < 0.2, variables were included in multivariable analyses to identify independent risk factors for local recurrence. Patients were then stratified by tourniquet usage (use/non-use), and risk from high blood pressure was evaluated in both subgroups. RESULTS: At an average follow-up of 6.8 ± 1.0 years, 63 of 411 patients (15.3%) experienced local recurrence. In multivariable analyses, local recurrence was associated with age (OR, 0.96; 95% CI, 0.94–0.99; p = 0.005); tumor type; lesion size (> 5 cm: OR, 3.58; 95% CI, 1.38–9.33; p = 0.009); anatomical site (proximal femur: OR, 2.49; 95% CI, 1.21–5.15; p = 0.014; proximal humerus: OR, 3.34; 95% CI, 1.61–6.92; p = 0.001); and preoperative mean arterial pressure (> 110 mmHg: OR, 2.61; 95% CI, 1.20–5.67; P = 0.015). In subgroup analyses, after adjusting for age, tumor type, lesion size, and anatomical site, tourniquet use modified the preoperative mean arterial pressure - recurrence relationship: when tourniquet was not used, preoperative mean arterial pressure predicted local recurrence (95–110 mmHg, 4.13, 1.42–12.03, p = 0.009; > 110 mmHg, 28.06, 5.27–149.30, p < 0.001); when tourniquet was used, preoperative mean arterial pressure was not related to local recurrence (all p values > 0.05). CONCLUSIONS: A high preoperative blood pressure was related to local recurrence after intralesional curettage for primary bone tumors in our study. Tourniquet usage and controlling blood pressure might be beneficial for reducing local recurrence in patients scheduled to receive intralesional curettage for primary bone tumor treatment. LEVEL OF EVIDENCE: Level IV, hypothesis-generating study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05157-4. BioMed Central 2022-03-03 /pmc/articles/PMC8892695/ /pubmed/35241034 http://dx.doi.org/10.1186/s12891-022-05157-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Lenian
Lin, Shanyi
Zhu, Hongyi
Dong, Yang
Yang, Qingcheng
Yuan, Ting
The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title_full The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title_fullStr The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title_full_unstemmed The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title_short The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
title_sort blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892695/
https://www.ncbi.nlm.nih.gov/pubmed/35241034
http://dx.doi.org/10.1186/s12891-022-05157-4
work_keys_str_mv AT zhoulenian thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT linshanyi thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT zhuhongyi thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT dongyang thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT yangqingcheng thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT yuanting thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT zhoulenian bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT linshanyi bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT zhuhongyi bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT dongyang bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT yangqingcheng bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy
AT yuanting bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy